Cargando…
2686. High HIV and STI Rates in Patients with MPOX Identified in a Large National Database
BACKGROUND: In mid-2022, mpox virus infection emerged outside of African countries to which it is endemic. Infections increased worldwide and were identified in 16 countries by late June 2022, with the US documenting the highest number of cases. Here we report patient characteristics and assess coin...
Autores principales: | Alfego, David, Dale, Suzanne, Curanovic, Dusica, Boles, Deborah, Williams, Jonathan, Harris, Ayla, Urban, Thomas J, Walworth, Charles M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677901/ http://dx.doi.org/10.1093/ofid/ofad500.2297 |
Ejemplares similares
-
117. Trends in Four-class HIV Drug Resistance in Treatment-experienced Patients in the United States
por: Curanovic, Dusica, et al.
Publicado: (2021) -
959. HIV-1 DNA Testing Identifies Drug Resistance in Viremic Patients with Pan-Sensitive Plasma Virus
por: Curanovic, Dusica, et al.
Publicado: (2020) -
HIV-1 DNA Testing in Viremic Patients Identifies More Drug Resistance Than HIV-1 RNA Testing
por: Curanovic, Dusica, et al.
Publicado: (2023) -
691. Results of Repeat HIV-1 DNA Resistance Tests Are Highly Concordant
por: Curanovic, Dusica, et al.
Publicado: (2020) -
Is mpox an STI? The societal aspects and healthcare implications of a key question
por: Garcia Iglesias, Jaime, et al.
Publicado: (2023)